Navigation Links
Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
Date:4/25/2009

- With half as many injections, in two pivotal Phase 3 trials, Albuferon (albinterferon alfa-2b) met the primary efficacy endpoint of sustained virologic response comparable to Pegasys (peginterferon alfa-2a) -

- Patients receiving 900-mcg Albuferon had comparable rates of serious and/or severe adverse events across the two Phase 3 trials, versus peginterferon alfa-2a -

- Submission of global marketing applications planned in fall 2009 -

ROCKVILLE, Md., April 25 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today reported that the final results of two pivotal Phase 3 trials demonstrate that Albuferon(R) (albinterferon alfa-2b) met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) in the treatment of patients with chronic hepatitis C. The Phase 3 results were the subject of two late-breaker oral presentations today in Copenhagen at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL). Albinterferon alfa-2b is being developed by HGS and Novartis under an exclusive worldwide co-development and commercialization agreement entered into in June 2006.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

"The Phase 3 data presented at EASL show that Albuferon, with half the injections, achieved a rate of sustained virologic response comparable to Pegasys," said David C. Stump, M.D., Executive Vice President, Research and Development, HGS. "Importantly, the rates of serious and/or severe adverse events were also comparable in these studies. We plan to file global marketing applications in fall 2009, following di
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
2. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
3. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
4. First Human Study to Show Sun Chlorella A Supports Heart Health
5. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
6. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
7. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
8. Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
9. Drug Development Program Started Based on CAP(R) Human Cell Line
10. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
11. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015 Aethlon Medical, Inc. ... address infectious diseases and cancer, today announced that ... to present a corporate overview at the 27th Annual ... Hotel in Laguna Niguel, California . ... ( http://www.roth.com/main/page.aspx?PageID=7207 ). A live webcast of ...
(Date:3/4/2015)... , March 4, 2015  Students from Indiana University ... how new medicines are discovered. Through a partnership with ... medical students from IU School of Medicine are learning ... at Lilly play different and important roles in bringing ... a former medical educator, scientific investigator, and health system ...
(Date:3/4/2015)... LAKE CITY , March 4, 2015  ECR ... VAR ) is showcasing a full spectrum of ... improve image quality, reduce costs, and enable greater patient ... cone-beam CT imaging systems.  These solutions are on display ... in Vienna, Austria this week.   ...
Breaking Medicine Technology:Aethlon Medical to Present at the 27th Annual ROTH Conference 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 3Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3
... 6, 2012 The American Veterinary Medical Association (AVMA) ... of cephalosporins in food animals appears consistent with the ... drug use, but warned against further restrictions not backed ... drug used in livestock, poultry and other food-producing animals, ...
... 6, 2012   RetireSafe , a 400,000-supporter ... of America,s seniors on issues regarding Social Security, Medicare, ... (ESI) to return to the negotiating table, and come ... patients whose pharmacy benefit plans are managed by Express ...
Cached Medicine Technology:AVMA Responds to Federal Order Limiting Use of Antibiotics In Food Animals 2RetireSafe Urges Express Scripts to Resume Contract Negotiations with Walgreens 2
(Date:3/4/2015)... 04, 2015 The ability of ... density assessment and help improve breast cancer risk ... accepted for presentation at the European Congress of ... abstracts - eight posters and 2 session presentations ... breast density and quantitative breast imaging software tools ...
(Date:3/4/2015)... Surrey, BC (PRWEB) March 04, 2015 ... will perform LASIK and PRK procedures at their new ... Vision Correction, Dr. Joseph King and Dr. Gabriel Chu ... ophthalmology practice in Surrey is named Fraser Valley Cataract ... facility is accredited by the College of Physicians and ...
(Date:3/4/2015)... State officials have awarded $82,500 to ... Public Health at Georgia State University, to support the ... Georgia’s Division of Family and Children Services (DFCS) as ... Center. , The 1-800-CHILDREN Helpline is a top ... referral services that promote the wellbeing of children while ...
(Date:3/4/2015)... 04, 2015 Organic Valley, the nation’s largest ... announced its cause campaign to Save the Bros, http://savethebros.com/ ... making a difference to Bros everywhere. To date, the ... Facebook. The video was named Adweek’s best commercial of ... Mashable and Digiday, among other media outlets. , “We ...
(Date:3/4/2015)... PEACHTREE CITY, GA (PRWEB) March 04, 2015 ... their exclusive advanced microfiber technology and their first compression ... the huge success of this collection, SIGVARIS USA is ... in the MIDTOWN MICROFIBER product line. , Constructed from ... designed with all-day comfort in mind. These socks and ...
Breaking Medicine News(10 mins):Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:King LASIK relocates to Surrey, British Columbia 2Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2
... George Abercrombie, president and,chief executive officer, ... leaders at the National Association of Corporate,Directors-Southern ... tell them,that the threat of a pandemic ... with traditional emergency preparedness plans., "While ...
... to develop the lung artery disorder, study shows , , WEDNESDAY, ... likely to develop a debilitating and potentially lethal lung disorder ... hypertension is caused by high blood pressure in the arteries ... the condition can become tired, dizzy and short of breath, ...
... Steven ,Cojo, Cojocaru forms Team Cojo to fight ... by his own life-saving,kidney transplant, fashion critic and ... to help the 12.5 million people,worldwide affected by ... of the world,s most common, life-threatening genetic,diseases, affecting ...
... gear up for the Thanksgiving holiday, a new research ... ( http://www.fasebj.org ), may provide some relief for those ... report, researchers describe a discovery that may allow some ... losing weight: they make a common antioxidant, melanin, in ...
... COLUMBIA, Mo. Health Literacy Month, recognized in ... understandable health information. According to the National Assessment ... have proficient health literacy - skills needed to ... populations is the focus of an ongoing study ...
... October 29, 2008 Shire plc (LSE: SHP, NASDAQ: ... from a 13-hour analog classroom study in school-aged children ... Disorder (ADHD). In this study, researchers found that ... measured (1.5 hours) through the last time point assessed ...
Cached Medicine News:Health News:CEO to Address Los Angeles Business Leaders About Developing Pandemic and Business Continuity Plans 2Health News:CEO to Address Los Angeles Business Leaders About Developing Pandemic and Business Continuity Plans 3Health News:Women at Higher Risk for Pulmonary Hypertension 2Health News:Cojo to Hit the Streets of LA for 2008 Walk for PKD 2Health News:New drug target in obesity: Fat cells make lots of melanin 2Health News:$8.6 million grant to MU will fund efforts to improve health literacy, health outcomes 2Health News:VYVANSE provided behavior, inattention and math test score improvements in children with ADHD 2Health News:VYVANSE provided behavior, inattention and math test score improvements in children with ADHD 3
PremierEdge™ MVR Knives. Angled....
VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Medicine Products: